Regarding ACE inhibitors/AT antagonists – like beta‐blockers – new, well‐designed trials are needed to specifically evaluate patients with AF and HF, not just dichotomously, that also break down and categorize AF according to type (paroxysmal vs. permanent) and duration. The gene discussed is ACE; the disease is hydrops fetalis.